221 related articles for article (PubMed ID: 29414605)
1. Use of induced pluripotent stem cell models to probe the pathogenesis of Choroideremia and to develop a potential treatment.
Duong TT; Vasireddy V; Ramachandran P; Herrera PS; Leo L; Merkel C; Bennett J; Mills JA
Stem Cell Res; 2018 Mar; 27():140-150. PubMed ID: 29414605
[TBL] [Abstract][Full Text] [Related]
2. Choroideremia: molecular mechanisms and development of AAV gene therapy.
Patrício MI; Barnard AR; Xue K; MacLaren RE
Expert Opin Biol Ther; 2018 Jul; 18(7):807-820. PubMed ID: 29932012
[TBL] [Abstract][Full Text] [Related]
3. Reduced Retinal Pigment Epithelial Autophagy Due to Loss of Rab12 Prenylation in a Human iPSC-RPE Model of Choroideremia.
Raeker MÖ; Perera ND; Karoukis AJ; Chen L; Feathers KL; Ali RR; Thompson DA; Fahim AT
Cells; 2024 Jun; 13(12):. PubMed ID: 38920696
[TBL] [Abstract][Full Text] [Related]
4. CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the retinal pigment epithelium of choroideremia mice.
Tolmachova T; Tolmachov OE; Wavre-Shapton ST; Tracey-White D; Futter CE; Seabra MC
J Gene Med; 2012 Mar; 14(3):158-68. PubMed ID: 22228595
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo.
Tolmachova T; Tolmachov OE; Barnard AR; de Silva SR; Lipinski DM; Walker NJ; Maclaren RE; Seabra MC
J Mol Med (Berl); 2013 Jul; 91(7):825-37. PubMed ID: 23756766
[TBL] [Abstract][Full Text] [Related]
6. Pathogenicity of a novel missense variant associated with choroideremia and its impact on gene replacement therapy.
Torriano S; Erkilic N; Faugère V; Damodar K; Hamel CP; Roux AF; Kalatzis V
Hum Mol Genet; 2017 Sep; 26(18):3573-3584. PubMed ID: 28911202
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CRISPR/Cas9 exon-skipping vector for choroideremia using human induced pluripotent stem cell-derived RPE.
Iwagawa T; Masumoto H; Tabuchi H; Tani K; Conklin BR; Watanabe S
J Gene Med; 2023 Feb; 25(2):e3464. PubMed ID: 36413603
[TBL] [Abstract][Full Text] [Related]
8. Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient.
Cereso N; Pequignot MO; Robert L; Becker F; De Luca V; Nabholz N; Rigau V; De Vos J; Hamel CP; Kalatzis V
Mol Ther Methods Clin Dev; 2014; 1():14011. PubMed ID: 26015956
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus 8-mediated gene therapy for choroideremia: preclinical studies in in vitro and in vivo models.
Black A; Vasireddy V; Chung DC; Maguire AM; Gaddameedi R; Tolmachova T; Seabra M; Bennett J
J Gene Med; 2014; 16(5-6):122-30. PubMed ID: 24962736
[TBL] [Abstract][Full Text] [Related]
10. Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia.
Toualbi L; Toms M; Almeida PV; Harbottle R; Moosajee M
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894906
[TBL] [Abstract][Full Text] [Related]
11. Choroideremia: molecular mechanisms and therapies.
Sarkar H; Moosajee M
Trends Mol Med; 2022 May; 28(5):378-387. PubMed ID: 35341685
[TBL] [Abstract][Full Text] [Related]
12. Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia.
Tolmachova T; Anders R; Abrink M; Bugeon L; Dallman MJ; Futter CE; Ramalho JS; Tonagel F; Tanimoto N; Seeliger MW; Huxley C; Seabra MC
J Clin Invest; 2006 Feb; 116(2):386-94. PubMed ID: 16410831
[TBL] [Abstract][Full Text] [Related]
13. The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy.
Torriano S; Erkilic N; Baux D; Cereso N; De Luca V; Meunier I; Moosajee M; Roux AF; Hamel CP; Kalatzis V
Sci Rep; 2018 May; 8(1):8234. PubMed ID: 29844446
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
[TBL] [Abstract][Full Text] [Related]
15. AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models.
Vasireddy V; Mills JA; Gaddameedi R; Basner-Tschakarjan E; Kohnke M; Black AD; Alexandrov K; Zhou S; Maguire AM; Chung DC; Mac H; Sullivan L; Gadue P; Bennicelli JL; French DL; Bennett J
PLoS One; 2013; 8(5):e61396. PubMed ID: 23667438
[TBL] [Abstract][Full Text] [Related]
16. Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia.
Tolmachova T; Wavre-Shapton ST; Barnard AR; MacLaren RE; Futter CE; Seabra MC
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4913-20. PubMed ID: 20445111
[TBL] [Abstract][Full Text] [Related]
17. Noncell-autonomous photoreceptor degeneration in a zebrafish model of choroideremia.
Krock BL; Bilotta J; Perkins BD
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4600-5. PubMed ID: 17360570
[TBL] [Abstract][Full Text] [Related]
18. Conditional ablation of the choroideremia gene causes age-related changes in mouse retinal pigment epithelium.
Wavre-Shapton ST; Tolmachova T; Lopes da Silva M; Futter CE; Seabra MC
PLoS One; 2013; 8(2):e57769. PubMed ID: 23460904
[TBL] [Abstract][Full Text] [Related]
19. Adeno-Associated Viral Gene Therapy for Inherited Retinal Disease.
Ong T; Pennesi ME; Birch DG; Lam BL; Tsang SH
Pharm Res; 2019 Jan; 36(2):34. PubMed ID: 30617669
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for choroideremia using an adeno-associated viral (AAV) vector.
Barnard AR; Groppe M; MacLaren RE
Cold Spring Harb Perspect Med; 2014 Oct; 5(3):a017293. PubMed ID: 25359548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
